Methods of treatment of menopause and perimenopause using eszopiclone
US7465729B2 · kind B2 · utility
16Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2005 |
| Grant date | Dec 16, 2008 |
| Priority date | — |
| Expiry date | Apr 27, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/498
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of eszopiclone for the treatment of symptoms accompanying perimenopause or menopause.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.